Local Institution

Elblag 82-300

0 studies enrolling now · 7 studies all time

What they study most

Acute Coronary Syndrome, Arthritis, Psoriatic, Atrial Fibrillation, Lung Cancer - Non Small Cell Squamous, Small Cell Lung Carcinoma, Type 2 Diabetes

Studies at this site

• Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy — Completed
• Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone — Completed
• Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin — Completed
• A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin — Completed